AMARANTUS BIOSCIEN (AMBS)

0.04
OTC Markets
Prev Close 0.04
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.01 / 0.21
Exchange OTC Markets
Shares Outstanding 68.27B
Market Cap 2.87M
Div & Yield N.A. (N.A)

Latest News

Amarantus Relocates Headquarters To WeWork At 110 Wall St. In New York City

Amarantus Relocates Headquarters To WeWork At 110 Wall St. In New York City

Temporary relocation reflects full commitment to complete capital restructuring

MANF Therapeutics Announces The Issuance Of U.S. Patent #9,891,231

MANF Therapeutics Announces The Issuance Of U.S. Patent #9,891,231

Covering Treatment of Diabetes with MANF

Amarantus Subsidiary MANF Therapeutics Announces Positive Independent Peer-Reviewed Pre-Clinical Data For MANF In Parkinson's Disease

Amarantus Subsidiary MANF Therapeutics Announces Positive Independent Peer-Reviewed Pre-Clinical Data For MANF In Parkinson's Disease

Data show in-animal increases in free-release dopamine and dopamine turnover

Amarantus Subsidiary Elto Pharma Receives Notice Of Allowance For European Patent Application Covering Method Of Treating Cognitive Impairment Associated With Alzheimer's Disease And Parkinson's Disease With Eltoprazine

Amarantus Subsidiary Elto Pharma Receives Notice Of Allowance For European Patent Application Covering Method Of Treating Cognitive Impairment Associated With Alzheimer's Disease And Parkinson's Disease With Eltoprazine

Once Issued, patent extends coverage for Eltoprazine in Europe into 2029 CEO to present at RedChip's Global Online Growth Conference on December 7, 2017

Amarantus Appoints Curtis Scribner, MD MBA As Sr. Vice President Of Regulatory Affairs

Amarantus Appoints Curtis Scribner, MD MBA As Sr. Vice President Of Regulatory Affairs

Dr. Scribner to Focus on Accelerated Regulatory Pathway for ESS

Amarantus To Present At The 2015 Aegis Growth Conference

Amarantus To Present At The 2015 Aegis Growth Conference

- Presentation and Live Webcast on October 9, 2015 at 11:25 a.m. PDT -